Inhibition of human recombinant B-Raf V600E mutant by FRET-based Z'-lyte assay
CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,15.27
C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=C(C=C2)F)C#CC3=CC4=C(NN=C4)N=C3)F,16.63
C1=CC=C(C(=C1)F)S(=O)(=O)NC2=C(C(=C(C=C2)F)C#CC3=CC4=C(NN=C4)N=C3)F,15.76
C1=CC(=CC(=C1)S(=O)(=O)NC2=C(C(=C(C=C2)F)C#CC3=CC4=C(NN=C4)N=C3)F)F,16.73
C1=CC(=CC=C1F)S(=O)(=O)NC2=C(C(=C(C=C2)F)C#CC3=CC4=C(NN=C4)N=C3)F,14.09
C1=CC=NC(=C1)S(=O)(=O)NC2=C(C(=C(C=C2)F)C#CC3=CC4=C(NN=C4)N=C3)F,15.14
C1=CC(=CN=C1)S(=O)(=O)NC2=C(C(=C(C=C2)F)C#CC3=CC4=C(NN=C4)N=C3)F,17.73
C1=CC(=CN=C1)S(=O)(=O)NC2=C(C(=C(C=C2)F)C#CC3=CC4=C(NC=C4)N=C3)F,17.83
C1=CC(=CN=C1)S(=O)(=O)NC2=C(C(=C(C=C2)F)C#CC3=CC4=C(C=C3)NN=C4)F,13.07
C1=CC(=CN=C1)S(=O)(=O)NC2=C(C(=C(C=C2)F)C#CC3=CN4C(=CC=N4)N=C3)F,15.25
COC1=NNC2=C1C=C(C=N2)C#CC3=C(C=CC(=C3F)NS(=O)(=O)C4=CN=CC=C4)F,17.6
CCOC1=NNC2=C1C=C(C=N2)C#CC3=C(C=CC(=C3F)NS(=O)(=O)C4=CN=CC=C4)F,15.18
CC1=C2C=C(C=NC2=NN1)C#CC3=C(C=CC(=C3F)NS(=O)(=O)C4=CN=CC=C4)F,17.87
C1CC1C2=C3C=C(C=NC3=NN2)C#CC4=C(C=CC(=C4F)NS(=O)(=O)C5=CN=CC=C5)F,17.72
C1=CC=C(C=C1)C2=C3C=C(C=NC3=NN2)C#CC4=C(C=CC(=C4F)NS(=O)(=O)C5=CN=CC=C5)F,15.99
C1=CC(=CN=C1)S(=O)(=O)NC2=C(C(=C(C=C2)F)C#CC3=CC4=C(NN=C4N=C3)C5=CC=NC=C5)F,17.45
C1=CC=C(C(=C1)C2=C3C=C(C=NC3=NN2)C#CC4=C(C=CC(=C4F)NS(=O)(=O)C5=CN=CC=C5)F)Cl,13.19
C1=CC(=CC(=C1)Cl)C2=C3C=C(C=NC3=NN2)C#CC4=C(C=CC(=C4F)NS(=O)(=O)C5=CN=CC=C5)F,13.36
C1=CC(=CN=C1)S(=O)(=O)NC2=C(C(=C(C=C2)F)C#CC3=CC4=C(NN=C4N=C3)C5=CC=C(C=C5)Cl)F,14.71
C1=CC(=CN=C1)S(=O)(=O)NC2=C(C(=C(C=C2)F)C#CC3=CC4=C(NN=C4N=C3)C5=CC=C(C=C5)F)F,15.74
